Bullish Moving Averages
16
Bearish Moving Averages
0
Back Stocks profile
Stock analysis tool for investors
Performance
Today’s low
54.00Today’s High
54.1052W low
20.6052W High
64.20Open Price
54.00Prev. Close
34.8000Volume
21473.00Value
1160830.38Fundamentals
Market Cap
16.50
Price to Earnings
129.00
Price to Book Value
4.70
Dividend Yield
0.00
PE to Growth
-3.20
Op Revenue TTM
0.26
Net Profit TTM
0.13
Cash From Operating Activity
-0.02
Return on Equity %
0.42
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
31 Jul, 2024
100
Week
100
Month
100
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
54.05
PIVOT
First Resistance
54.07
Second Resistance
54.07
Third Resistance
54.09
First Support
54.05
Second Support
54.03
Third Support
54.03
Relative Strength Index
59.88
Money Flow Index
96.08
MACD
1.71
MACD Signal
1.78
Average True Range
1.95
Average Directional Index
28.08
Rate of Change (21)
-7.11
Rate of Change (125)
46.07
Commodity Channel Index
81.3
Williams %R
-6.8
BETA
1 Month
1.62
3 Month
1.07
1 Year
0.57
3 Year
PRICE CHANGE ANALYSIS
↑ 3.96%
1 Week
Low
High
51
54.06
↓ -11.64%
1 Month
Low
High
42.94
64.2
↑ 76.84%
3 Months
Low
High
28.36
64.2
↑ 46.66%
6 Months
Low
High
28.36
64.2
↑ 148.78%
1 Year
Low
High
20.65
64.2
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Graph |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Qtr Revenue cr | 0.16 | 0.00 | 0.04 | 0.07 | 0.06 | 1.01 | 0.68 | 0.03 | 1.05 | 0.01 | 0.10 | 0.03 | 0.02 | |
| Operating Expenses Qtr | 0.03 | 0.04 | 0.02 | 0.04 | 0.03 | 0.06 | 0.64 | 0.05 | 1.09 | 0.32 | 0.05 | 0.04 | 0.04 | |
| Operating Profit Qtr | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 | 0.93 | 0.03 | -0.03 | -0.06 | -0.32 | -0.03 | -0.01 | -0.02 | |
| EBIDT Qtr Cr | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 | 0.97 | -0.85 | 0.07 | 0.47 | 0.10 | 0.05 | -0.01 | -0.02 | |
| Depreciation Qtr | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.01 | 0.01 | -0.05 | 0.04 | 0.05 | 0.05 | |
| Net Profit Qtr | 0.13 | -0.04 | 0.02 | 0.02 | 0.03 | 0.98 | -0.85 | 0.06 | 0.46 | 0.15 | 0.01 | -0.06 | -0.11 | |
| Basic EPS Qtr | 0.42 | -0.15 | 0.07 | 0.08 | 0.09 | 3.21 | -2.79 | 0.20 | 1.50 | 0.48 | 0.04 | -0.19 | -0.36 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total Revenue Annual | 0.17 | 2.77 | 0.15 | 0.21 | 0.86 | |
| Operating Expenses Annual Cr | 0.15 | 1.84 | 0.45 | 0.35 | 0.30 | |
| Operating Profit Annual | 0.01 | 0.88 | -0.38 | -0.14 | 0.55 | |
| Operating Profit Margin Annual % | 8.88 | 31.77 | -244.47 | -65.44 | 63.92 | |
| Total Expenses Annual Cr | 0.15 | 1.85 | 0.58 | 0.71 | 0.65 | |
| EBIDT Annual Cr | 0.02 | 0.92 | -0.29 | -0.14 | 0.56 | |
| EBIDT Annual margin % | 9.78 | 33.31 | -190.11 | -64.05 | 65.56 | |
| Depreciation | 0.00 | 0.01 | 0.08 | 0.19 | 0.18 | |
| PAT Before ExtraOrdinary Items Annual Cr | 0.02 | 0.65 | -0.43 | -0.56 | 0.29 | |
| Net Profit Annual | 0.02 | 0.65 | -0.01 | -0.56 | 0.29 | |
| Basic EPS Annual | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Total ShareHolders Funds Annual | 3.54 | 3.53 | 2.88 | 4.49 | 5.05 | |
| Minority Interest Liability Annual Cr | - | - | - | - | - | |
| Total Non Current Liabilities Annual Cr | 0.00 | 0.00 | 0.70 | 2.26 | 2.19 | |
| Total Current Liabilities Annual Cr | 0.79 | 0.89 | 0.21 | 0.87 | 0.77 | |
| Total Capital Plus Liabilities Annual Cr | 4.33 | 4.42 | 3.80 | 7.62 | 8.01 | |
| Fixed Assets Annual | 0.00 | 0.00 | 1.75 | 6.35 | 4.96 | |
| Total Non Current Assets Annual | 1.42 | 1.84 | 2.66 | 7.45 | 7.60 | |
| Total Current Assets Annual | 2.91 | 2.58 | 1.14 | 0.16 | 0.40 | |
| Total Assets Annual | 4.33 | 4.42 | 3.80 | 7.62 | 8.01 | |
| Contingent Liabilities plus Commitments Annual Cr | - | 0.00 | 0.00 | 0.00 | 0.00 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Cash from Operating Activity Annual | -0.02 | -0.78 | -2.13 | 1.48 | 0.44 | |
| Cash from Investing Activity Annual | -0.02 | 1.52 | 3.67 | -1.58 | -0.47 | |
| Cash from Financing Annual Activity | 0.00 | -0.70 | -1.55 | 0.07 | 0.00 | |
| Net Cash Flow Annual | -0.04 | 0.04 | -0.01 | -0.03 | -0.04 |
| Indicator | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Graph |
|---|---|---|---|---|---|---|
| Book Value Per Share Annual | 11.60 | 11.55 | 9.42 | 14.69 | 16.52 | |
| ROE Annual % | 0.42 | 18.38 | -0.32 | -12.45 | 5.66 | |
| ROCE Annual % | 0.42 | 25.89 | -10.55 | -4.80 | 5.32 | |
| Total Debt to Total Equity Annual | 0.00 | 0.17 | 0.00 | 0.34 | 0.29 | |
| EBDIT Annual Margin % | 9.87 | 33.83 | -416.43 | -64.94 | 66.64 |
| Indicator | Graph |
|---|---|
| Total Qtr Revenue cr | |
| Operating Expenses Qtr | |
| Operating Profit Qtr | |
| EBIDT Qtr Cr | |
| Depreciation Qtr | |
| Net Profit Qtr | |
| Basic EPS Qtr |
| Indicator | Graph |
|---|---|
| Total Revenue Annual | |
| Operating Expenses Annual Cr | |
| Operating Profit Annual | |
| Operating Profit Margin Annual % | |
| Total Expenses Annual Cr | |
| EBIDT Annual Cr | |
| EBIDT Annual margin % | |
| Depreciation | |
| PAT Before ExtraOrdinary Items Annual Cr | |
| Net Profit Annual | |
| Basic EPS Annual |
| Indicator | Graph |
|---|---|
| Total ShareHolders Funds Annual | |
| Minority Interest Liability Annual Cr | |
| Total Non Current Liabilities Annual Cr | |
| Total Current Liabilities Annual Cr | |
| Total Capital Plus Liabilities Annual Cr | |
| Fixed Assets Annual | |
| Total Non Current Assets Annual | |
| Total Current Assets Annual | |
| Total Assets Annual | |
| Contingent Liabilities plus Commitments Annual Cr |
| Indicator | Graph |
|---|---|
| Cash from Operating Activity Annual | |
| Cash from Investing Activity Annual | |
| Cash from Financing Annual Activity | |
| Net Cash Flow Annual |
| Indicator | Graph |
|---|---|
| Book Value Per Share Annual | |
| ROE Annual % | |
| ROCE Annual % | |
| Total Debt to Total Equity Annual | |
| EBDIT Annual Margin % |
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|
| Name | Holding Percent | Holding Id | Pledged % | Locked % |
|---|---|---|---|---|
| Yogesh Agrawal | 54.78 | 88969588 | 0 | 0 |
| Parul Agrawal | 9.29 | 88969589 | 0 | 0 |
| Name | Holding Percent | Holding Id |
|---|
| Name | Holding Percent | Holding Id |
|---|---|---|
| Deepti Aggarwal | 11 | 88969597 |
| Amar Aggarwal | 9.05 | 88969598 |
| Harish Chandra Sharma | 4.81 | 88969599 |
| HUF | 0.57 | 88969593 |
| Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|
| Ex-Date | Split Ratio | Record Date |
|---|
| Ex-Date | Purpose | Notes |
|---|---|---|
| Jul 29, 2024 | Quarterly Results | - |
| May 09, 2024 | Audited Results | - |
| Feb 14, 2024 | Quarterly Results | (Revised) |
| Nov 14, 2023 | Quarterly Results | (Revised) |
| Aug 14, 2023 | Quarterly Results | - |
| May 29, 2023 | Audited Results | - |
| Feb 10, 2023 | Quarterly Results | - |
| Nov 12, 2022 | Quarterly Results | - |
| Jul 20, 2022 | Quarterly Results | - |
| May 28, 2022 | Audited Results & Quarterly Results | - |
| Feb 12, 2022 | Quarterly Results | - |
| Nov 12, 2021 | Quarterly Results | - |
| Aug 10, 2021 | Quarterly Results | - |
| Jun 29, 2021 | Audited & Quarterly Results | - |
| Feb 11, 2021 | Quarterly Results | - |
| Dec 05, 2020 | A.G.M. | - |
| Nov 11, 2020 | Quarterly Results | - |
| Sep 15, 2020 | Quarterly Results | - |
| Jun 29, 2020 | Audited Results & Quarterly Results | - |
| Feb 14, 2020 | Quarterly Results | - |
| Nov 12, 2019 | Quarterly Results | - |
| Jul 28, 2019 | Quarterly Results & A.G.M. | - |
| Jul 06, 2019 | A.G.M. & Others | Inter alia, to consider and approve : To approve Board Report along with CG Report, MDA and all other necessary Annexures for the FY ended March 31, 2019. |
| Jun 25, 2019 | Others | Inter alia, to consider and approve : 1. Re-appointment of Mrs. Parual Agrawal, Director 2. Re-appointment of Mr. Rajesh Kumar Saxena as an ID |
| May 30, 2019 | Audited Results | - |
| Feb 13, 2019 | Quarterly Results | - |
| Jan 21, 2019 | Others | Authorisation for entering, executing and signing the Memorandum of Understanding with Khadi and Village Industries Commission. |
| Nov 05, 2018 | Quarterly Results | - |
| Aug 10, 2018 | Quarterly Results | - |
| May 30, 2018 | Audited Results | - |
| Feb 03, 2018 | Quarterly Results | - |
| Nov 13, 2017 | Quarterly Results | - |
| Sep 13, 2017 | Quarterly Results | (Revised) |
| May 29, 2017 | Audited Results | - |
| Feb 11, 2017 | Quarterly Results | - |
| Nov 12, 2016 | Quarterly Results | - |
| Aug 04, 2016 | Quarterly Results | - |
| May 30, 2016 | Resignation of CFO | - |
| Feb 09, 2016 | Others | Appointment of Mr. Vikas Garg for the Post of Company Secretary & Compliance Officer w.e.f. February 09, 2016 and he will join the office w.e.f. April 01, 2016. |
| Jan 11, 2016 | Quarterly Results | 1. Approving the Change of RTA from Link Intime India Private Limited to BEETAL Financial & Computer Services Private Limited. 2. Signing of Uniform Listing Agreement according SEBI Regulation 2015. |
| Nov 09, 2015 | Quarterly Results | - |
| Aug 07, 2015 | Quarterly Results | - |
| Ex-Date | Bonus Ratio | Record Date |
|---|
01 Aug 2024
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Please find enclosed News Paper Publication of Financial Results
29 Jul 2024
Genomic Valley Biotech Ltd - 539206 - Submission Of Un-Audited Standalone Financial Results For The Quarter Ended On June 30, 2024
Please find enclosed herewith the Un- Audited Standalone financial result for the quarter ended on June 30,2024 .
29 Jul 2024
Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of The Board Meeting Pursuant To Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Held On Today I.E., 29Th July, 2024
To Considered and approved the standalone Un-Audited financial results of the Company for the quarter ended 30th June, 2024. A copy of the said standalone Un-audited financial results along with the Limited review report from statuary auditor is enclosed herewith.
23 Jul 2024
Genomic Valley Biotech Ltd - 539206 - Board Meeting Intimation for Intimation Regarding Holding Of Board Meeting On 29Th July, 2024 To Consider Un-Audited Financial Results For The Quarter Ended June 30, 2024
Genomic Valley Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/07/2024 ,inter alia, to consider and approve Intimation regarding Holding of Board Meeting on 29th July, 2024 to consider Un-Audited Financial Results for the quarter ended June 30, 2024
15 Jul 2024
Genomic Valley Biotech Ltd - 539206 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed
13 May 2024
Genomic Valley Biotech Ltd - 539206 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement regarding publication of Financial Results for the quarter and year ended March 31, 2024.
09 May 2024
Genomic Valley Biotech Ltd - 539206 - Non-Applicability Of Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Non applicability of Reg 23(9) is enclosed herewith
09 May 2024
Genomic Valley Biotech Ltd - 539206 - Audited Financial Results For The Period Ended March 31, 2024
Results are enclosed herewith:
09 May 2024
Genomic Valley Biotech Ltd - 539206 - Board Meeting Outcome for Outcome Of Board Meeting
Outcome of the Board Meeting is enclosed.
